Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study von Reid, Tony, Prof, Oronsky, Bryan, MD, Scicinski, Jan, PhD, Scribner, Curt L, MD, Knox, Susan J, MD, Ning, Shoucheng, MD, Peehl, Donna M, Prof, Korn, Ron, MD, Stirn, Meaghan, MBA, Carter, Corey A, MD, Oronsky, Arnold, MD, Taylor, Michael J, PhD, Fitch, William L, PhD, Cabrales, Pedro, PhD, Kim, Michelle M, MD, Burris, Howard A, MD, Lao, Christopher D, MD, Abrouk, Nacer E D, PhD, Fanger, Gary R, PhD, Infante, Jeffrey R, MD

Volltext

Is Nitric Oxide (NO) the Last Word in Radiosensitization? A Review von Oronsky, Bryan T, Knox, Susan J, Scicinski, Jan J

Volltext

Rewriting the Epigenetic Code for Tumor Resensitization: A Review von Oronsky, Bryan, Oronsky, Neil, Scicinski, Jan, Fanger, Gary, Lybeck, Michelle, Reid, Tony

Volltext

The capacity of red blood cells to reduce nitrite determines nitric oxide generation under hypoxic conditions von Fens, Marcel H, Larkin, Sandra K, Oronsky, Bryan, Scicinski, Jan, Morris, Claudia R, Kuypers, Frans A

Volltext

Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance von Oronsky, Bryan, Carter, Corey A, Reid, Tony R, Scicinski, Jan, Oronsky, Arnold, Lybeck, Michelle, Caroen, Scott, Stirn, Meaghan, Oronsky, Neil, Langecker, Peter

Volltext

Six Degrees of Separation: The Oxygen Effect in the Development of Radiosensitizers von Oronsky, Bryan T, Knox, Susan J, Scicinski, Jan

Volltext

The Scarlet Letter of Alkylation: A Mini Review of Selective Alkylating Agents von Oronsky, Bryan T, Reid, Tony, Knox, Susan J, Scicinski, Jan J

Volltext

No patient left behind: The promise of immune priming with epigenetic agents von Carter, Corey A., Oronsky, Bryan T., Roswarski, Joseph, Oronsky, Arnold L., Oronsky, Neil, Scicinski, Jan, Lybeck, Harry, Kim, Michelle M., Lybeck, Michelle, Reid, Tony R.

Volltext

Partial Response to Platinum Doublets in Refractory EGFR-Positive Non-Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization von Carter, Corey A., Oronsky, Bryan T., Caroen, Scott Z., Scicinski, Jan J., Cabrales, Pedro, Reid, Tony, Degesys, Aiste, Jenkins, John, Brzezniak, Christina

Volltext

Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome von Carter, Corey A., Scicinski, Jan J., Lybeck, Harry E., Oronsky, Bryan T.

Volltext

Beyond Antiangiogenesis: Vascular Modulation as an Anticancer Therapy—A Review von Oronsky, Bryan T, Scicinski, Jan J, Reid, Tony, Knox, Susan

Volltext

The Case of a Zebra That Was Misdiagnosed as a Horse: Pulmonary Tumor Thrombotic Microangiopathy, a New Paraneoplastic Syndrome, Mimicking PD-1-Induced Pneumonitis von Carter, Corey A., Browning, Robert, Oronsky, Bryan T., Scicinski, Jan J., Brzezniak, Christina

Volltext

Episensitization: Defying Time's Arrow von Oronsky, Bryan T, Oronsky, Arnold L, Lybeck, Michelle, Oronsky, Neil C, Scicinski, Jan J, Carter, Corey, Day, Regina M, Rodriguez Orengo, Jose F, Rodriguez-Torres, Maribel, Fanger, Gary F, Reid, Tony R

Volltext

RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report von Brzezniak, Christina, Schmitz, Bruno A., Peterson, Paul G., Degesys, Aiste, Oronsky, Bryan T., Scicinski, Jan J., Caroen, Scott Z., Carter, Corey A.

Volltext

RRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum Doublets von Carter, Corey A., Oronsky, Bryan T., Caroen, Scott Z., Scicinski, Jan J., Degesys, Aiste, Kim, Michelle M., Oronsky, Arnold L., Lybeck, Harry, Cabrales, Pedro, Oronsky, Neil, Reid, Tony, Roswarski, Joseph, Brzezniak, Christina

Volltext

A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001 von Oronsky, Bryan, Caroen, Scott, Zeman, Karen, Quinn, Mary, Brzezniak, Christina, Scicinski, Jan, Cabrales, Pedro, Reid, Tony R., Trepel, Jane B., Abrouk, Nacer D., Larson, Christopher, Oronsky, Arnold, Lybeck, Harry E., Day, Regina M., Carter, Corey A.

Volltext

The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent von Scicinski, Jan, Fisher, George, Carter, Corey, Cho-Phan, Cheryl, Kunz, Pamela, Ning, Shoucheng, Knox, Susan, Oronsky, Bryan, Caroen, Scott, Parker, Christopher, Fanger, Gary, Reid, Tony

Volltext

Impact of hemoglobin nitrite to nitric oxide reductase on blood transfusion for resuscitation from hemorrhagic shock von Brouse, Chad, Ortiz, Daniel, Su, Yan, Oronsky, Bryan, Scicinski, Jan, Cabrales, Pedro

Volltext

Light-fluorous safety-catch arylgermanes - exceptionally robust, photochemically activated precursors for biaryl synthesis by Pd(0) catalysed cross-coupling von Spivey, Alan C, Tseng, Chih-Chung, Hannah, Joseph P, Gripton, Christopher J G, de Fraine, Paul, Parr, Nigel J, Scicinski, Jan J

Volltext

Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001 von Carter, Corey A., Schmitz, Bruno, Peterson, P. Gabriel, Quinn, Mary, Degesys, Aiste, Jenkins, John, Oronsky, Bryan, Scicinski, Jan, Caroen, Scott, Reid, Tony R., Cabrales, Pedro, Brzezniak, Christina

Volltext